Caris Life Sciences Raises $168M in Growth

Caris Life Sciences has successfully raised $168M in a Growth at a $1.9B valuation led by Braidwell.

Company Overview

Caris Life Sciences is a Biotech company headquartered in Irving, TX, founded in 2018 with 1000+ employees.

Molecular profiling and AI/ML for precision medicine development

Fundraising Details

Amount Raised: $168M
Round Type: Growth
Valuation: $1.9B
Date: 2025-10-06
Investors: Braidwell

About Caris Life Sciences

Molecular profiling and AI/ML for precision medicine development The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: Irving, TX
Founded: 2018
Team Size: 1000+
Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in Caris Life Sciences's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Caris Life Sciences's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $1.9B valuation marks an important milestone for Caris Life Sciences, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, Caris Life Sciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-10-06. For more information about Caris Life Sciences, visit their headquarters at Irving, TX.